Even a smoker's lungs are better than no lungs at all, concluded a British study that found transplant patients who receive lungs from smokers have a better chance of survival than those who stay on waiting lists, hoping for a healthier set.
Patients who need new lungs are better off getting donated organs from smokers than none at all, even though they probably won't live as long as those who get a lung transplant from a nonsmoker, a new study says.
With more than 90,000 U.S. patients needing kidneys, only a dramatic expansion in living donations would meet the growing demand for organs.
Kelowna kid Ashlyn Lang, who suffers from a life-threatening disease and needs a new liver, is getting one — all the way from New Zealand. The three-year-old is getting the new organ courtesy of her half-sister Allison Lang, 21, who lives in New Zeal…
Transplant patients are turning to social networks in ever greater numbers in their desperate search for organs – and appear to be getting results. Researchers examined nearly 100 Facebook pages set up to find living kidney donors for patients aged fro…
Multiple myeloma patients are better equipped to halt progression of this blood cancer if treated with lenalidomide, or Revlimid-, following a stem cell transplant, according to a study co-authored by a physician with the Oregon Health & Science Univer…
New Oregon Health & Science University study adds to evidence that blood cancer drug called Lenalidomide can be effective, even as feds warn of additional risk to taking it.
( Oregon Health & Science University ) Multiple myeloma patients are better equipped to halt progression of this blood cancer if treated with lenalidomide, or Revlimid, following a stem cell transplant, according to a study co-authored by a physician w…
Doctors at the Korle-Bu Teaching Hospital (KBTH) will begin undertaking kidney transplantation in the last quarter of this year. This will bring great relief to many kidney patients in the country who need kidney transplant but cannot afford the high c…
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today commented on findings of the Chronic Disease Research Group (CDRG) study showing that patients receiving daily, or more frequent, home hemodialysis with the NxStage Sy…